Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Trials
|
February 7, 2026
Effects of prescribed medical cannabis and alcohol on real-world driving performance (CAN-TRACK): a study protocol for a two-phase trial
Thomas R Arkell, Amie C Hayley, Blair Aitken, et al.
Nature
|
April 12, 2001
Induction of the mammalian node requires Arkadia function in the extraembryonic lineages
V Episkopou, R Arkell, P M Timmons, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 12, 2024
Driving performance and ocular activity following acute administration of 10 mg methylphenidate: A randomised, double-blind, placebo-controlled study
Blair Aitken, Luke A Downey, Serah Rose, et al.
Nature and Science of Sleep
|
April 24, 2023
Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey
Anastasia Suraev, Llewellyn Mills, Sarah V Abelev, et al.
Accident; Analysis and Prevention
|
October 5, 2020
Driving-Related Behaviours, Attitudes and Perceptions among Australian Medical Cannabis Users: Results from the CAMS 18-19 Survey
Thomas R Arkell, Nicholas Lintzeris, Llewellyn Mills, et al.
Genomics
|
November 23, 2000
Cloning, mapping, and expression analysis of a gene encoding a novel mammalian EGF-related protein (SCUBE1)
S Grimmond, R Larder, N Van Hateren, et al.
Mechanisms of Development
|
April 5, 2001
Expression of a novel mammalian epidermal growth factor-related gene during mouse neural development
S Grimmond, R Larder, N Van Hateren, et al.
Human Psychopharmacology
|
February 11, 2025
Acute Administration of 10 mg Methylphenidate on Cognitive Performance and Visual Scanning in Healthy Adults: Randomised, Double-Blind, Placebo-Controlled Study
Blair Aitken, Luke A Downey, Serah Rose, et al.
Plos One
|
February 14, 2024
Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study
Benjamin T Trevitt, Sasha Bailey, Llewellyn Mills, et al.
JAMA
|
December 1, 2020
Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial
Thomas R Arkell, Frederick Vinckenbosch, Richard C Kevin, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Trials
|
February 7, 2026
Effects of prescribed medical cannabis and alcohol on real-world driving performance (CAN-TRACK): a study protocol for a two-phase trial
Thomas R Arkell, Amie C Hayley, Blair Aitken, et al.
Nature
|
April 12, 2001
Induction of the mammalian node requires Arkadia function in the extraembryonic lineages
V Episkopou, R Arkell, P M Timmons, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 12, 2024
Driving performance and ocular activity following acute administration of 10 mg methylphenidate: A randomised, double-blind, placebo-controlled study
Blair Aitken, Luke A Downey, Serah Rose, et al.
Nature and Science of Sleep
|
April 24, 2023
Medical Cannabis Use Patterns for Sleep Disorders in Australia: Results of the Cross-Sectional CAMS-20 Survey
Anastasia Suraev, Llewellyn Mills, Sarah V Abelev, et al.
Accident; Analysis and Prevention
|
October 5, 2020
Driving-Related Behaviours, Attitudes and Perceptions among Australian Medical Cannabis Users: Results from the CAMS 18-19 Survey
Thomas R Arkell, Nicholas Lintzeris, Llewellyn Mills, et al.
Genomics
|
November 23, 2000
Cloning, mapping, and expression analysis of a gene encoding a novel mammalian EGF-related protein (SCUBE1)
S Grimmond, R Larder, N Van Hateren, et al.
Mechanisms of Development
|
April 5, 2001
Expression of a novel mammalian epidermal growth factor-related gene during mouse neural development
S Grimmond, R Larder, N Van Hateren, et al.
Human Psychopharmacology
|
February 11, 2025
Acute Administration of 10 mg Methylphenidate on Cognitive Performance and Visual Scanning in Healthy Adults: Randomised, Double-Blind, Placebo-Controlled Study
Blair Aitken, Luke A Downey, Serah Rose, et al.
Plos One
|
February 14, 2024
Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study
Benjamin T Trevitt, Sasha Bailey, Llewellyn Mills, et al.
JAMA
|
December 1, 2020
Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial
Thomas R Arkell, Frederick Vinckenbosch, Richard C Kevin, et al.
Page
of 4